Individually Owned Inventions Clause Samples

Individually Owned Inventions. Except as the Parties may otherwise agree in writing, all Inventions (as defined herein) which are conceived, reduced to practice, or created by a Party in the course of performing its obligations under this Agreement shall be solely-owned and subject to use and exploitation by the inventing Party without a duty to account to the other Party.
Individually Owned Inventions. Except as the parties may otherwise agree in writing, all Inventions (as defined herein) which are conceived, reduced to practice, or created by a party in the course of performing its obligations under this Agreement shall be solely owned and subject to use and exploitation by the inventing party without a duty to account to the other party. For purposes of this Agreement, “Invention” shall mean information relating to any innovation, improvement, development, discovery, computer program, device, trade secret, method, know-how, process, technique or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable.
Individually Owned Inventions. Subject to and except as otherwise provided under Section 10.1, and except as the parties may otherwise agree in writing, all Inventions which are conceived, reduced to practice, or created by a party in the course of performing its obligations under or resulting from this Agreement shall be solely owned and subject to use and exploitation by the inventing party without a duty to account to the other party, provided that ▇▇▇▇▇▇ shall promptly disclose such Inventions to Client and, upon request, ▇▇▇▇▇▇ shall grant Client a [***] license [(***)] to practice any intellectual property created by ▇▇▇▇▇▇ in the course of performing its obligations under this Agreement, to the extent necessary for Client to make, have made, use, sell, offer and import Client Product.
Individually Owned Inventions. Except as the parties may otherwise agree in writing, all Inventions that are conceived, reduced to practice, or created solely or jointly by a party in the course of performing its obligations under this Agreement and that (a) pertain specifically to the Client Product or Bulk Compound, including, without limitation, that are specific to the manufacture or reconstitution of Client Product and Bulk Compound, or (b) are derived from or incorporate Client’s Confidential Information (collectively, “Product Inventions”) shall be solely owned and subject to use and exploitation by Client, and ▇▇▇▇▇▇ hereby assigns all right, title and interest in such Product Inventions and Intellectual Property therein to Client. ▇▇▇▇▇▇ agrees to execute such assignments and other documents, to cause its employees and contractors to execute such assignments and other documents, and to take such other actions as may be reasonably requested by Client, at Client’s expense, from time to time in order to effect to the ownership provisions of this Section 14.2. With respect to Inventions that are conceived, reduced to practice, or created by a party in the course of performing its obligations under this Agreement and are not Product Inventions, the following terms of ownership shall apply: Client shall solely own all such Inventions made solely by employees and/or contractors of Client (the “Client’s Project Intellectual Property”); and ▇▇▇▇▇▇ shall solely own such Inventions made solely by employees and/or contractors of ▇▇▇▇▇▇ (the “Althea’s Project Intellectual Property”).
Individually Owned Inventions. Except as the parties may otherwise agree in writing, all Inventions (as defined herein) which are conceived, reduced to practice, or created by a party in the course of performing its obligations under this Agreement shall be solely owned and subject to use and exploitation by the inventing party without a duty to account to the other party. For purposes of this Agreement, "Invention" shall mean any invention, innovation, improvement, development, discovery, computer program, device, trade secret, method, know-how, process, technique or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable. BAXTER hereby grants to CLIENT a royalty-free, non-exclusive, worldwide license (with the right to grant sublicenses) under all patent rights and other intellectual property rights covering Inventions which are conceived, reduced to practice, or created by BAXTER in the course of performing its obligations under this Agreement and which relate directly to the Bulk Conjugated Antibody or other CLIENT Supplied Components.
Individually Owned Inventions. Except as the parties may otherwise agree in writing, any Invention (as defined herein) which is conceived, reduced to practice, or created by Polymed in the course of performing its obligations under this Agreement as it relates to the Products and Intellectual Property shall be solely owned by InovaChem, whether or not InovaChem is the inventing party. Any and all use and exploitation of the Invention shall be solely at the discretion of InovaChem. For purposes of this Agreement, "Invention" shall mean any invention, innovation, improvement, development, discovery, computer program, device, trade secret, method, know-how, process, technique or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable. Polymed shall assign, or cause to be assigned, to InovaChem all patent rights and other intellectual property rights covering any Invention.
Individually Owned Inventions. Except as the parties may otherwise agree in writing, all Inventions (as defined herein) which are conceived, reduced to practice, or created by a party in the course of performing its obligations under this Agreement shall be solely owned and subject to use and exploitation by the inventing party without a duty to account to the other party, provided, however, any Inventions or changes to CLIENT’s Drug Product formulation shall be owned solely by CLIENT. For purposes of this Agreement, “Invention” shall mean information relating to any innovation, improvement, development, discovery, computer program, device, trade secret, method, know-how, process, technique or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable.
Individually Owned Inventions. 12.2.1 Except as the parties may otherwise agree in writing, all Inventions (as defined herein) which are conceived, reduced to practice, or created by a party in the course of performing its obligations under this Agreement shall be solely owned and subject to use and exploitation by the inventing party without a duty to account to the other party. For purposes of this Agreement, “Invention” shall mean information relating to any innovation, improvement, development, discovery, computer program, device, trade secret, method, know-how, process, technique or the like, whether or not written or otherwise fixed in any form or medium, regardless of the media on which contained and whether or not patentable or copyrightable. Baxter hereby grants to Halozyme a royalty-free, non-exclusive, worldwide license (with the right to grant sublicenses) under all patent rights and other intellectual property rights specifically describing and claiming Inventions which are conceived, reduced to practice, or created by Baxter in the course of performing its obligations under this Agreement and which in each case (i) use or are supported by data and information derived from the use of recombinant human PH20 hyaluronidase or are derived from the activities under this Agreement, and (ii) only to the extent they relate to recombinant human PH20 hyaluronidase, its manufacture or use, and expressly excluding any intellectual property rights that were not conceived, reduced to practice or created by Baxter under this Agreement. Halozyme shall use commercially reasonable efforts to obtain a similar grantback license from any third party that enters into a development agreement with Halozyme for rights to make and sell products comprising recombinant human PH20 hyaluronidase, and if Halozyme is unable to obtain such a grantback license from any such third party, then Halozyme shall not grant a sublicense to such third party under the license grant from Baxter under this Section 12.2.1, and any such sublicense granted by Halozyme to such third party shall be void. 12.2.2 The party solely owning any Invention shall have the world-wide right to control the drafting, filing, prosecution and maintenance of patents covering the Invention, including decisions about the countries in which to file patent applications. Patent costs associated with the patent activities described in this Section 12.2.2 shall be borne by the sole owner.
Individually Owned Inventions. Subject to Section 12.1, all Inventions which are conceived, reduced to practice, or created solely by one Party during the Term of this Agreement and which do not apply or relate specifically and directly only to the Argos Product and/or Critical Starting Materials for the Argos Product or to a Party’s explicit written obligations under this Agreement or the PWA shall be solely owned and subject to use, exploitation, licensing and commercialization by the inventing Party without a duty to account to the other Party.